MedWatch

Serious setback for Genmab in DuoBody collaboration

Genmab has suffered a significant setback for one of the early clinical assets being developed in a collaboration with Janssen after a phase I study has been put on clinical hold.

Photo: PR Genmab

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

William Demant går mod trenden i jagt på fortsat vækst

Når storproducenten af høreapparater William Demant om få uger lancerer en stribe nye produkter, vil der være tale om nye tilbud til kunderne, der ellers går mod den globale trend, hvor høreapparatets elektronik placeres bag øret.

Related articles